Start Date
January 31, 2008
Primary Completion Date
May 31, 2010
Study Completion Date
May 31, 2010
Levetiracetam 1 g IV + Lorazepam 2 mg IV
Levetiracetam 1 g IV + Lorazepam 2 mg IV
Placebo + Lorazepam 3 mg IV
Placebo + Lorazepam 3 mg IV
Collaborators (1)
UCB Pharma
INDUSTRY
Massachusetts General Hospital
OTHER